Page last updated: 2024-11-05

3-bromopyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

3-bromopyridine is a heterocyclic aromatic compound that serves as a versatile building block in organic synthesis. It is a key intermediate in the preparation of various pharmaceuticals, agrochemicals, and other fine chemicals. The compound can be synthesized through various methods, including bromination of pyridine using bromine in the presence of a catalyst, or by reaction of pyridine with N-bromosuccinimide. 3-bromopyridine has been shown to exhibit diverse biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. Its importance in research stems from its potential applications in drug discovery and development. For example, it has been used as a starting material for the synthesis of several promising drug candidates, including inhibitors of enzymes involved in various disease processes. Additionally, 3-bromopyridine serves as a valuable reagent in the preparation of various functionalized heterocyclic compounds, expanding its utility in chemical synthesis and discovery.'

Cross-References

ID SourceID
PubMed CID12286
CHEBI ID51575
SCHEMBL ID6350
MeSH IDM0507399

Synonyms (45)

Synonym
einecs 210-952-0
unii-xmn8h2xe9h
ai3-17853
xmn8h2xe9h ,
nsc 3974
3-bromopyridine ,
626-55-1
nsc-3974
nsc3974
pyridine, 3-bromo-
inchi=1/c5h4brn/c6-5-2-1-3-7-4-5/h1-4
3-bromopyridine, 99%
B0651
STK802249
AKOS000119193
A833908
3-bromopyridine;3-bromopyridine, stabilized with copper chip
3-bromo-pyridine
5-bromopyridine
c5h4brn
CHEBI:51575
3-pyridyl bromide
BP-13125
FT-0615250
PS-4257
AM20061386
AB00739
CX1091
BBL027581
SCHEMBL6350
pyridin-3-yl bromide
m-bromopyridine
DTXSID9060819
3-bromo pyridine
5-bromo-pyridine
3-bromopryidine
3-bromopyridin
W-104971
STR04425
mfcd00006373
F0001-1682
BCP22223
CS-0008362
Q223057
EN300-19110
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monobromopyridine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.93 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index45.80 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]